APA (7th ed.) Citation

Zhang, C., Xu, P., Wang, Y., Chen, X., Pan, Y., Ma, Z., . . . Xia, H. (2025). STK39 inhibits antiviral immune response by inhibiting DCAF1-mediated PP2A degradation. Acta Pharmaceutica Sinica B, 15(3), 1535. https://doi.org/10.1016/j.apsb.2024.12.034

Chicago Style (17th ed.) Citation

Zhang, Chengfei, et al. "STK39 Inhibits Antiviral Immune Response by Inhibiting DCAF1-mediated PP2A Degradation." Acta Pharmaceutica Sinica B 15, no. 3 (2025): 1535. https://doi.org/10.1016/j.apsb.2024.12.034.

MLA (9th ed.) Citation

Zhang, Chengfei, et al. "STK39 Inhibits Antiviral Immune Response by Inhibiting DCAF1-mediated PP2A Degradation." Acta Pharmaceutica Sinica B, vol. 15, no. 3, 2025, p. 1535, https://doi.org/10.1016/j.apsb.2024.12.034.